LeMaitre Vascular: The Compounder Keeps Compounding [Seeking Alpha]
LeMaitre Vascular, Inc. (LMAT)
Last lemaitre vascular, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
lemaitre.gcs-web.com/investor-relations
Company Research
Source: Seeking Alpha
Artegraft's international rollout exceeded expectations, with 2025 sales doubling guidance and a projected $10M in 2026. This could drive earnings growth for years to come. LMAT maintains a robust $190M net cash position and recently increased its dividend by 25%. The board has also authorized a $100M share repurchase program. Operating leverage, pricing power, and international expansion are all key drivers in raising my price target to $116-$130 for year-end 2026. I reiterate my Buy rating. Alberto Marrupe Gutierrez/iStock via Getty Images I last covered LeMaitre Vascular ( NASDAQ: LMAT ) at $81 in June 2025 , reiterating my Buy rating. Eight months later, shares are up about 35%, more than double that of the broader market. The stock jumped ~20% alone on the recent Q4 beat and raise, with 2026 This article was written by Analyst's Disclosure: I/we have a beneficial long position in the shares of LMAT either through stock ownership, options, or other derivatives. I wrot
Show less
Read more
Impact Snapshot
Event Time:
LMAT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LMAT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LMAT alerts
High impacting LeMaitre Vascular, Inc. news events
Weekly update
A roundup of the hottest topics
LMAT
News
- LeMaitre to Participate at Upcoming Investor Conferences in March [Yahoo! Finance]Yahoo! Finance
- LeMaitre to Participate at Upcoming Investor Conferences in MarchGlobeNewswire
- LeMaitre Vascular (LMAT) had its price target raised by Barrington Research from $95.00 to $105.00. They now have an "outperform" rating on the stock.MarketBeat
- LeMaitre Vascular (LMAT) had its "buy" rating reaffirmed by Roth Mkm. They now have a $117.00 price target on the stock, up from $108.00.MarketBeat
- LeMaitre Vascular (LMAT) had its price target raised by Wells Fargo & Company from $87.00 to $94.00. They now have an "equal weight" rating on the stock.MarketBeat
LMAT
Earnings
- 2/25/26 - Beat
LMAT
Sec Filings
- 2/27/26 - Form 144
- 2/27/26 - Form 144
- 2/26/26 - Form 144
- LMAT's page on the SEC website